Title : covid 19 and pregnancy vaccination: Challenges and concerns
Abstract:
The 2019-nCoV (or COVID-19) outbreak began in Wuhan and has since spread throughout China and the world. A increase in new diseases and deaths poses severe public health and governance concerns in Wuhan. Governments have taken required activities such as limiting cross-city travel, case detection and contact tracing, quarantine, public education, and creation of detection kits with the help of the federal government. The society's unity has considerably decreased challenges including shortage of efficient medications, healthcare services, medical supplies, and logistics. The epidemic will be ended with the ongoing efforts of national and international multi-sectoral bodies. 48.5 % of the world's population has had a COVID-19 vaccine. Globally, 6.84 billion doses have been given, with 25.52 million given daily. Only 3% of low-income persons have received one dosage. Simultaneously, many COVID-19 vaccines have been created and approved at a breakneck pace, all while adhering to stringent regulatory requirements. Pregnant women had a greater risk of severe illness, ICU admission, and invasive ventilation compared to non-pregnant patients of the same age. As a result, pregnant women are designated a high-risk population for COVID-19 infection.. A passive approach to pregnant, puerperal, and breastfeeding women's requests for vaccination does not justify the absence of evidence on the efficacy and evaluation of immunological response to the SARS-CoV-2 vaccine. It is crucial to recognize that during the pregnancy-puerperal cycle, women are at a greater risk of severe COVID-19, and their children are at an increased risk of the detrimental effects of preterm delivery, providing a compelling argument for primary prevention.
